Italia markets close in 1 hour 59 minutes

FTSE MIB
34.806,23
+313,82(+0,91%)
Dow Jones
38.720,90
+34,58(+0,09%)
Nasdaq
16.860,68
+125,66(+0,75%)
Nikkei 225
38.923,03
+435,13(+1,13%)
Petrolio
76,53
-0,46(-0,60%)
Bitcoin EUR
64.138,87
+1.455,75(+2,32%)

NVCR Dec 2025 30.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

11,70

0,00

(0,00%)

In data: 02:53PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in